...
机译:Phase Ⅱ study of intrathecal administration of trastuzumab in patients with HER2-positive breast cancer with leptomeningeal metastasis
Department of Oncology, Institut Curie-St Cloud, 92210, Saint Cloud, France;
Department of Genetics, Institut Curie-Paris, 75005, Paris, France;
Neuro-Oncology Neurosurgery Department, University of Lille France, CHU Lille, France , Neurology, Department of Medical Oncology, Centre Oscar Lambret, Lille, FranceDepartment of Oncology, Centre Leon Berard, 69008, Lyon, FranceDepartment of Clinical Research, Institut Curie-St Cloud, 92210, Saint Cloud, FranceDepartment of Biostatistics, Institut Curie-St Cloud, 92210, Saint Cloud, FranceDepartment of Neurology Mazarin, Groupe Hospitalier Pitie-SalpEtriere, 75013, Paris, FranceDepartment of Surgery, Institut Curie-St Cloud, 92210, Saint Cloud, France, INSERM U900, Institut Curie-St Cloud, Saint Cloud, France;
HER2-positive breast cancer; intrathecal treatment; lepto-meningeal carcinomatosis; trastuzumab;